• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Multiple Sclerosis Thought Leader Panel #18 2013-05 - Product Image

Multiple Sclerosis Thought Leader Panel #18 2013-05

  • ID: 2754881
  • May 2013
  • Region: North America
  • 120 Pages
  • Medpredict

FEATURED COMPANIES

  • Acorda / Mayo
  • Bayer
  • Biogen-Idec / Abbott
  • GSK / Genmab
  • Medimmune
  • Novartis / Kyorin
  • MORE

The Multiple Sclerosis Thought Leader Panel #18 2013-05 summarizes a series of interviews conducted with Neurology Thought leaders after the AAN 2013.

The objectives of these discussions was to highlight differential clinical advantages that are extrapolatable from the trial data that was presented, and to get their opinions on meaningful new pipeline activities in relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.

The Panel weighs in on the following topics:

- Unmet needs in multiple sclerosis (RRMS, SPMS and PPMS)
- S1P agonists: me-toos and meaningful differences
- Tecfidera; uptake, malignancy, PML, renal
- Aubagio clinical / marketing challenges
- laquinimod and the CONCERTO trial
- Tysabri: risk vs reward
- B-cell approaches; CD20 vs CD19
- Role for daclizumab
- Targeting IL7 / TH17
- PEGylated Interferon
- Achievable benefits above standard of care in RRMS, SPMS and PPMS
- Remyelination strategies; including small molecules, MAbs and stem cell approaches

Drugs mentioned in the main body of this report include:

- rHIgM22
- ponesimod
- MAPC
- interferon beta-1b
- READ MORE >

FEATURED COMPANIES

  • Acorda / Mayo
  • Bayer
  • Biogen-Idec / Abbott
  • GSK / Genmab
  • Medimmune
  • Novartis / Kyorin
  • MORE

For full table of contents see free sample download.

- Acorda / Mayo
- Actelion
- Athersys / Pfizer
- Bayer-Schering / Sanofi
- Bayer
- Biogen-Idec
- Biogen-Idec / Abbott
- Biogen-Idec / Elan
- Biogen-Idec / Genentech / Roche
- GSK
- GSK / Genmab
- Karolinska Institutet
- Lexicon
- Medimmune
- Merck-Serono / Pfizer
- Novartis
- Novartis / Kyorin
- Ono / Merck-Serono
- Opexa
- Receptos
- Sanofi-Aventis
- Shenzhen Beike Bio-Technology
- Stanford University / Wernig
- Teva / Sanofi-Aventis Teva

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos